论文部分内容阅读
东维力(左卡尼汀口服溶液)由东北制药生产,是国内首个左卡尼汀口服制剂,其在原发性左卡尼汀缺乏症、有机酸血症、预防丙戊酸治疗导致的肝毒性、儿童肥胖方面的疗效和安全性已得到了广大临床医师的认可。为了总结东维力在儿科疾病治疗方面的临床应用经验,进一步评估该药的临床疗效、应用范围及安全性,加强学术交流合作,促进合理用药,使患儿获得更大的帮助,
East Weili (L-carnitine oral solution) produced by Tohoku Pharmaceutical Co., Ltd., is the first oral formulation of L-carnitine, which in the primary L-carnitine deficiency, organic acidosis, prevention of valproate treatment results Hepatotoxicity, efficacy and safety of childhood obesity has been recognized by the majority of clinicians. In order to summarize the experience of clinical application of East Weili in the treatment of pediatric diseases, further evaluate the clinical efficacy, application scope and safety of this drug, strengthen academic exchanges and cooperation, promote rational drug use and make children get more help.